Learn More
Medchemexpress LLC ELR510444 | 1233948-35-0 | 98.0% | 368.47 | 25 MG

Supplier: Medchemexpress LLC 25MGHY16191
ELR510444 is a novel microtubule disruptor that inhibits MDA-MB-231 cell proliferation and exhibits potent antitumor activity. It is not a substrate for the P-glycoprotein drug transporter, maintaining activity in βIII-tubulin-overexpressing cell lines, thereby circumventing drug resistance. This compound also shows potential antivascular effects by decreasing HIF-1α and HIF-2α levels, reducing renal cell carcinoma (RCC) cell viability and clonogenic survival, and inducing apoptosis to significantly reduce tumor burden in RCC xenograft models. For research use only.
- Inhibits MDA-MB-231 cell proliferation with an IC50 of 30.9 nM
- Circumvents drug resistance mechanisms by not being a P-glycoprotein substrate
- Demonstrates potent antitumor activity in MDA-MB-231 xenograft model
- Exhibits potential antivascular effects
- Reduces renal cell carcinoma (RCC) cell viability and induces apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.